Literature DB >> 18300944

Functional characterization of a -100_-102delAAG deletion-insertion polymorphism in the promoter region of the HTR3B gene.

Cornelia Meineke1, Mladen Vassilev Tzvetkov, Kristin Bokelmann, Elke Oetjen, Karen Hirsch-Ernst, Rolf Kaiser, Jürgen Brockmöller.   

Abstract

OBJECTIVE: The HTR3B gene encodes the B-subunit of the type 3 serotonin receptor (5-HT3). A -100_-102delAAG deletion in the promoter region has been associated with poor response to antiemetic medication and susceptibility to bipolar affective disorders. The molecular mechanisms underlying these associations, however, remained unclear.
METHODS: We performed electrophoretic mobility shift and luciferase reporter gene assays to elucidate the effect of this polymorphism on the HTR3B promoter activity in PC-12 and HEK293 cells. The reporter constructs carried a 2171 bp fragment of the native HTR3B promoter or 30 bp of the polymorphic locus in tandem triplication upstream of the thymidine kinase minimal promoter.
RESULTS: Deletion mapping indicated that the sequence around the -100_-102delAAG polymorphism had significant promoter activity. Electrophoretic mobility shift assays indicated differential binding of nuclear proteins to the polymorphic DNA region with stronger binding to the insertion than to the deletion allele. The activity of the native promoter carrying the deletion allele was 25% higher in PC-12 (P=0.016) and 40% higher in HEK cells (P=0.016) compared with the respective insertion construct. Constructs carrying the deletion allele in tandem triplicates showed 43% (PC-12 cells, P=0.002) and 28% (HEK293 cells, P=0.015) higher activity than those carrying the insertion allele. The polymorphism was not linked with known amino acid substitutions in HTR3A and HTR3B.
CONCLUSIONS: The -100_-102delAAG 3 bp deletion increases the HTR3B promoter activity in vitro. The consequences of this for the structure and the function of the resulting 5-HT3 receptors remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18300944     DOI: 10.1097/FPC.0b013e3282f51092

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  9 in total

Review 1.  A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting.

Authors:  Komal P Singh; Anand A Dhruva; Elena Flowers; Kord M Kober; Christine Miaskowski
Journal:  Crit Rev Oncol Hematol       Date:  2017-11-20       Impact factor: 6.312

Review 2.  Allosteric modulation of the 5-HT(3) receptor.

Authors:  Paul A Davies
Journal:  Curr Opin Pharmacol       Date:  2011-02-20       Impact factor: 5.547

Review 3.  The 5-HT3 receptor--the relationship between structure and function.

Authors:  Nicholas M Barnes; Tim G Hales; Sarah C R Lummis; John A Peters
Journal:  Neuropharmacology       Date:  2008-08-12       Impact factor: 5.250

Review 4.  3B but which 3B and that's just one of the questions: the heterogeneity of human 5-HT3 receptors.

Authors:  Anders A Jensen; Paul A Davies; Hans Bräuner-Osborne; Karen Krzywkowski
Journal:  Trends Pharmacol Sci       Date:  2008-09       Impact factor: 14.819

5.  Hepatocyte nuclear factor 1 regulates the expression of the organic cation transporter 1 via binding to an evolutionary conserved region in intron 1 of the OCT1 gene.

Authors:  Valerie P O'Brien; Kristin Bokelmann; Jacqueline Ramírez; Karoline Jobst; Mark J Ratain; Jürgen Brockmöller; Mladen V Tzvetkov
Journal:  J Pharmacol Exp Ther       Date:  2013-08-06       Impact factor: 4.030

Review 6.  Does pharmacogenomics account for variability in control of acute chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists?

Authors:  Morgan Trammel; Mary Roederer; Jai Patel; Howard McLeod
Journal:  Curr Oncol Rep       Date:  2013-06       Impact factor: 5.075

7.  Pharmacogenetic predictors of nausea and vomiting of pregnancy severity and response to antiemetic therapy: a pilot study.

Authors:  Amalia S Lehmann; Jamie L Renbarger; Catherine L McCormick; Ariel R Topletz; Carrie Rouse; David M Haas
Journal:  BMC Pregnancy Childbirth       Date:  2013-06-20       Impact factor: 3.007

8.  Replication of functional serotonin receptor type 3A and B variants in bipolar affective disorder: a European multicenter study.

Authors:  C Hammer; S Cichon; T W Mühleisen; B Haenisch; F Degenhardt; M Mattheisen; R Breuer; S H Witt; J Strohmaier; L Oruc; F Rivas; G Babadjanova; M Grigoroiu-Serbanescu; J Hauser; R Röth; G Rappold; M Rietschel; M M Nöthen; B Niesler
Journal:  Transl Psychiatry       Date:  2012-04-17       Impact factor: 6.222

9.  Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting.

Authors:  Min-Soo Kim; Jeong-Rim Lee; Eun-Mi Choi; Eun Ho Kim; Seung Ho Choi
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.